Ignite Creation Date:
2025-12-25 @ 4:42 AM
Ignite Modification Date:
2025-12-26 @ 3:43 AM
Study NCT ID:
NCT01594918
Status:
COMPLETED
Last Update Posted:
2017-07-21
First Post:
2012-05-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer
Sponsor:
Rahul Aggarwal
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UCSF Protocol No. 11951
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |